Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort

20261 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov identifier: NCT03746522.

Published in: Obesity

Volume 34, Issue 3, pp. 579-587

Field-Weighted Citation Impact: 29.31